Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.1849
+0.0069 (3.88%)
At close: Apr 1, 2025, 4:00 PM
0.1780
-0.0069 (-3.73%)
After-hours: Apr 1, 2025, 4:37 PM EDT
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $9.66 million as of April 1, 2025. Its market cap has decreased by -18.82% in one year.
Market Cap
9.66M
Enterprise Value
8.25M
1-Year Change
-18.82%
Ranking
Category
Stock Price
$0.18
Market Cap Chart
Since December 1, 1998, Ernexa Therapeutics's market cap has decreased from $21.10M to $9.66M, a decrease of -54.22%. That is a compound annual growth rate of -2.92%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 31, 2025 | 9.30M | -38.41% |
Dec 31, 2024 | 15.10M | 55.67% |
Dec 29, 2023 | 9.70M | 2.11% |
Dec 30, 2022 | 9.50M | -95.62% |
Dec 31, 2021 | 217.00M | 3,187.88% |
Dec 31, 2020 | 6.60M | 3.13% |
Dec 31, 2019 | 6.40M | 14.29% |
Dec 31, 2018 | 5.60M | -47.17% |
Dec 29, 2017 | 10.60M | -44.79% |
Dec 30, 2016 | 19.20M | 29.73% |
Dec 31, 2015 | 14.80M | -63.55% |
Dec 31, 2014 | 40.60M | -10.18% |
Dec 31, 2013 | 45.20M | 203.36% |
Dec 31, 2012 | 14.90M | -1.97% |
Dec 30, 2011 | 15.20M | -34.20% |
Dec 31, 2010 | 23.10M | -15.07% |
Dec 31, 2009 | 27.20M | 262.67% |
Dec 31, 2008 | 7.50M | -78.07% |
Dec 31, 2007 | 34.20M | -54.22% |
Dec 29, 2006 | 74.70M | -6.74% |
Dec 30, 2005 | 80.10M | -52.55% |
Dec 31, 2004 | 168.80M | -3.87% |
Dec 31, 2003 | 175.60M | 272.03% |
Dec 31, 2002 | 47.20M | 42.17% |
Dec 31, 2001 | 33.20M | 52.29% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 741.66B |
UnitedHealth Group | 479.08B |
Johnson & Johnson | 399.65B |
AbbVie | 370.64B |
Novo Nordisk | 302.16B |
Abbott Laboratories | 230.06B |
Merck & Co. | 226.74B |
AstraZeneca | 225.46B |